AstraZeneca Pharmaceuticals LP v. Food & Drug Administration

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• applying Chevron to an FDA statutory interpretation contained in a letter decision
• applying Chevron to an FDA statutory interpretation contained in a letter decision
• “ANDAs need not include new clinical studies 2 demonstrating . . . safety or efficacy, but must propose the same basic labeling as approved for the pioneer drug.”
• applying Chevron to FDA’s letter decision interpreting the FDCA

Source: CourtListener parenthetical corpus (CC0).